Explore our insights

Union Budget 2026 signals a decisive pivot in India’s health policy to build the full stack required for an innovation-led, patient-centred health economy.

Explore Grant Thornton Bharat’s pre-Budget 2026 insights across sectors including automotive, banking, technology, infrastructure, healthcare, taxation, and investment priorities shaping India’s economic, regulatory, and policy landscape.

As India prepares for a defining fiscal moment, the Union Budget 2026–27 is expected to set the tone for the country’s next growth cycle. At a time of shifting global dynamics and evolving domestic priorities, this Budget will be closely watched for clear signals on reform momentum, investment focus, and economic resilience.

India’s healthcare and pharma sector saw strong growth powered by investments, policy reforms, digital health and AI-driven innovation.

The Pharma and Healthcare Dealtracker Q3 2025 by Grant Thornton Bharat analyses India’s evolving life sciences ecosystem, highlighting a 28% surge in deal volumes and a 166% rise in values. The report explores M&A, private equity, and capital market activity shaping pharma, healthcare, and biotech growth.

India and Japan have evolved their relationship into a strong, strategic partnership focused on shared growth and prosperity. This alliance is built on a foundation of economic collaboration, cultural resonance, spiritual connection, and centuries-old civilisational ties. Together, the two nations have made significant strides in navigating the challenges of globalisation and technological change, further deepening their mutual bond.

GST overhaul cuts tax on medicines & devices, making healthcare affordable. Pharma and medtech must realign pricing, supply chains, and innovation to drive access and growth.

Discover how mid-market businesses can seize global trade opportunities in 2025. Explore a five-point action plan to navigate economic uncertainty, leverage new trade agreements and outpace larger competitors in a shifting global economy.

The report captures sector-wise shifts, investor alignment with scalable and tech-integrated models, and emerging preferences in early-stage innovation.

The first quarter of 2025 reflected sustained investor attention in India’s healthcare and pharmaceutical sector, marked by consistent deal activity and strategic alignment with long-term growth drivers.

Get insights on Q3 2024 pharma and healthcare deals covers record-high domestic deals, PE trends, and capital market activity reshaping India's healthcare industry.

Q1 2024 sees a decline in Indian healthcare & pharma deals. Despite challenges, long-term prospects remain strong. Explore insights now.

Discover how the Interim Budget 2024 fosters healthcare transformation in India, emphasizing prevention and empowerment. Explore insights with Grant Thornton Bharat.

This report was released at the Annual Conclave of Association of Healthcare Providers India (AHPI) on 2 February 2024 in Gandhinagar, Gujarat, where Grant Thornton Bharat was the knowledge partner.

Discover the Interim Budget 2024 Wishlist for the Insurance Industry by Grant Thornton Bharat. Expectations for higher deductions and tax exemptions.

This publication covers the performance of the pharma and healthcare sector in Q3.